Cicek-Saydam C.Cavusoglu C.Burhanoglu D.Hilmioglu S.Ozkalay N.Bilgic A.2019-10-272019-10-2720011198-743Xhttps://doi.org/10.1046/j.1469-0691.2001.00341.xhttps://hdl.handle.net/11454/28003The aim of this study was to determine the in vitro susceptibility of 170 clinical isolates of Mycobacterium tuberculosis to fusidic acid using a proportion dilution method. Nineteen isolates were resistant to at least one first-line anti-tuberculosis drug. A total of 1.8% of the isolates were resistant to fusidic acid. Fusidic acid should be evaluated clinically as a potential supplementary drug for the treatment of infections due to multidrug-resistant strains of M. tuberculosis.en10.1046/j.1469-0691.2001.00341.xinfo:eu-repo/semantics/openAccessArticle71270070211843915Q1